DBJ Capital Co., Ltd., established in June 2010, is a corporate venture capital investment arm of the Development Bank of Japan, located in Tokyo. The firm emerged from the integration of two venture capital entities within the DBJ Group. DBJ Capital focuses on investing in companies that leverage new technologies and innovative business models across various industries to enhance their competitive edge in the global market. The company offers tailored investment solutions, including equity investments and financing options, utilizing the extensive resources of the DBJ Group. In addition to capital investment, DBJ Capital provides hands-on support to help startups commercialize their intellectual property and technologies developed by firms, research labs, and universities. By fostering the growth of the companies it invests in, DBJ Capital aims to contribute to Japan's economic revival and stimulate the creation of new industries within the country.
NearMe Inc. is a Tokyo-based company that specializes in a mobile application designed for taxi ride-sharing services. Founded in 2017, the application facilitates instant matching of individuals traveling in the same direction, addressing inefficiencies in transportation and commuting. By enabling users to share taxi rides in real time, NearMe aims to improve the commuting experience and promote a more sustainable community. The platform addresses social inefficiencies by connecting users with similar travel interests, ultimately contributing to a more comfortable and efficient commuting solution.
Cellusion
Series C in 2023
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.
Techtouch
Series B in 2023
Techtouch, Inc. is a Tokyo-based company founded in 2018 that specializes in developing TechTouch, a digital transformation platform designed to improve operational efficiency for businesses. Its software provides an intuitive website user manual by overlaying explanatory guidance directly onto existing web systems through a browser plug-in and server-side integration. This approach allows for real-time navigation assistance, minimizing the challenges associated with complex system operations. By enhancing system education for employees and promoting better utilization of web resources, Techtouch aims to reduce operational burdens and streamline business processes.
Spacely
Venture Round in 2022
Spacely, Inc. is a cloud software company based in Tokyo, Japan, that specializes in the creation and editing of virtual reality (VR) content. Founded in 2013 and previously known as 3D Stylee until its rebranding in 2018, Spacely offers an intuitive platform that allows users to manage VR web content using photos captured with 360-degree cameras. The software caters to various industries, including real estate, tourism, and retail, enabling businesses to develop their own VR services through an application programming interface (API). By simplifying the VR content creation process, Spacely aims to provide a seamless experience for users looking to engage audiences through immersive digital experiences.
Cellusion
Venture Round in 2022
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.
Sprocket
Series C in 2021
Sprocket Inc., founded in 2014 and based in Tokyo, Japan, specializes in developing customer development applications. The company offers a web-based platform that enhances customer service by optimizing conversion rates through the analysis of user behavior. Sprocket's solution allows businesses to implement a continuous improvement cycle by formulating hypotheses, conducting tests, and evaluating results based on key performance indicators and goals. Its tools are designed to foster long-term relationships between companies and their end users, improving the overall customer experience across various industries. The platform is compatible with both Android and iOS, making it accessible to a wide range of users.
nearMe
Series A in 2020
NearMe Inc. is a Tokyo-based company that specializes in a mobile application designed for taxi ride-sharing services. Founded in 2017, the application facilitates instant matching of individuals traveling in the same direction, addressing inefficiencies in transportation and commuting. By enabling users to share taxi rides in real time, NearMe aims to improve the commuting experience and promote a more sustainable community. The platform addresses social inefficiencies by connecting users with similar travel interests, ultimately contributing to a more comfortable and efficient commuting solution.
Alivas
Series A in 2020
Alivas Inc. is a medical company based in Hongo, Tokyo, Japan, that specializes in developing therapeutic medical devices aimed at treating refractory constipation. Founded in 2017, Alivas emerged as a joint venture between Stanford University and the University of Tokyo, leveraging the Japan Biodesign program to foster innovative solutions in medical device creation. The company's primary focus is on addressing intractable chronic constipation, providing patients with effective treatment options to alleviate their condition and improve their quality of life.
Techtouch
Series A in 2020
Techtouch, Inc. is a Tokyo-based company founded in 2018 that specializes in developing TechTouch, a digital transformation platform designed to improve operational efficiency for businesses. Its software provides an intuitive website user manual by overlaying explanatory guidance directly onto existing web systems through a browser plug-in and server-side integration. This approach allows for real-time navigation assistance, minimizing the challenges associated with complex system operations. By enhancing system education for employees and promoting better utilization of web resources, Techtouch aims to reduce operational burdens and streamline business processes.
Photoruction
Venture Round in 2020
Photoruction, Inc. is a Tokyo-based company that specializes in providing internet services tailored for the construction industry. Founded in 2016, Photoruction offers a cloud platform designed for construction photography and civil engineering support. Its flagship product facilitates the documentation of construction processes through an app that allows architects, construction teams, and landowners to capture, save, and share blueprints and photographs. The platform digitizes traditionally paper-based workflows, automates the organization of albums and photos, and enhances data sharing capabilities. Additionally, Photoruction develops an AI-driven engine that interprets information from drawings and photographs, aiming to streamline various phases of construction projects, from design to procurement. This technology enables clients to significantly reduce operational time and enhance productivity.
TVISION INSIGHTS
Venture Round in 2020
TVISION INSIGHTS is a company that measures the "viewing quality" of television. Utilizing state-of-the-art human body recognition technology developed by TVISION, it is rare in the world to acquire TV viewing status in the living room and convert it into data, and a very unique data set that does not exist is founded It has been acquired and accumulated since then. Currently, we have expanded our bases globally and have expanded to Tokyo, Boston and New York. While challenging challenges in different markets,we are continuing to grow rapidly to realize the original potential of TV.
Ginco
Series A in 2020
Ginco Inc. is a Tokyo-based company established in 2017 that specializes in blockchain technology and cryptocurrency solutions. Its primary product is the Ginco mobile cryptocurrency wallet, which enables users to manage various digital assets securely through multi-signature technology. The wallet supports multiple cryptocurrencies, including Bitcoin, Ethereum, and Ripple, and is designed to accommodate both hot and cold wallet functionalities. In addition to its wallet services, Ginco offers crypto mining, enterprise wallet solutions, and node management services. The company's mission is to reshape the relationship between individuals and their assets by leveraging blockchain technology, with plans to expand into decentralized exchanges and other facets of the evolving digital currency ecosystem.
Cellusion
Series A in 2020
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.
nearMe
Series A in 2019
NearMe Inc. is a Tokyo-based company that specializes in a mobile application designed for taxi ride-sharing services. Founded in 2017, the application facilitates instant matching of individuals traveling in the same direction, addressing inefficiencies in transportation and commuting. By enabling users to share taxi rides in real time, NearMe aims to improve the commuting experience and promote a more sustainable community. The platform addresses social inefficiencies by connecting users with similar travel interests, ultimately contributing to a more comfortable and efficient commuting solution.
GITAI
Series A in 2019
GITAI Inc. is a leading space robotics company based in Tokyo, Japan, established in 2016. The firm specializes in manufacturing humanoid telepresence robots to assist with tasks related to space exploration, particularly within space stations and lunar development. GITAI's product lineup includes the G1 robot, designed for general-purpose automation, the S1 robot for specific task automation, and the H1 manipulation system for remote operation of robots in space. By providing a reliable alternative to human labor, GITAI aims to enhance safety, improve efficiency, and significantly reduce operational costs in space activities. Their technology is intended to facilitate the construction and maintenance of satellites, space stations, and future habitats on the Moon and Mars, ultimately enabling more sustainable and cost-effective space exploration.
Spacely
Series A in 2019
Spacely, Inc. is a cloud software company based in Tokyo, Japan, that specializes in the creation and editing of virtual reality (VR) content. Founded in 2013 and previously known as 3D Stylee until its rebranding in 2018, Spacely offers an intuitive platform that allows users to manage VR web content using photos captured with 360-degree cameras. The software caters to various industries, including real estate, tourism, and retail, enabling businesses to develop their own VR services through an application programming interface (API). By simplifying the VR content creation process, Spacely aims to provide a seamless experience for users looking to engage audiences through immersive digital experiences.
Trajectory
Venture Round in 2019
Trajectory, Ltd. is a Tokyo-based company established in 2018 that specializes in the research and development of control systems for unmanned aerial vehicles (UAVs). The company has created an AI Traffic Control system that facilitates fully autonomous navigation for drones. Its innovative technology allows for the automated generation of flight routes for multiple UAVs, enabling simultaneous deployment and operation. By providing clients with a safe and accessible environment for UAV usage, Trajectory aims to address various operational challenges associated with unmanned aircraft.
Alivexis
Series A in 2018
Alivexis is a preclinical stage drug discovery company based in Tokyo, specializing in the rapid design and generation of small molecule clinical candidates aimed at addressing high-value disease targets. The company leverages advanced computational drug discovery techniques and unique biological insights to accelerate the development of new medicines. Its international team consists of experts in drug design and disease biology, drawing on extensive research and development experience from global pharmaceutical and biotechnology firms. Alivexis's platform is designed to enhance biotechnological research, ultimately enabling healthcare professionals to deliver effective treatments to patients with unmet medical needs.
TL Genomics
Venture Round in 2018
TL Genomics Co., Ltd., founded in 2015 and based in Tokyo, Japan, specializes in DNA testing services with a focus on prenatal diagnosis. The company has developed a unique technology that isolates fetal nucleated red blood cells from maternal blood, allowing for non-invasive examination of the fetal genome. This innovative approach facilitates early and definitive diagnosis of fetal chromosomal disorders during pregnancy. Additionally, TL Genomics offers laminated microfluidic devices that enhance the efficiency of cell fractionation, thereby supporting healthcare providers in ensuring safe pregnancies for their patients.
Spacely
Seed Round in 2018
Spacely, Inc. is a cloud software company based in Tokyo, Japan, that specializes in the creation and editing of virtual reality (VR) content. Founded in 2013 and previously known as 3D Stylee until its rebranding in 2018, Spacely offers an intuitive platform that allows users to manage VR web content using photos captured with 360-degree cameras. The software caters to various industries, including real estate, tourism, and retail, enabling businesses to develop their own VR services through an application programming interface (API). By simplifying the VR content creation process, Spacely aims to provide a seamless experience for users looking to engage audiences through immersive digital experiences.
Megakaryon
Series C in 2017
Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.
Timers
Venture Round in 2017
Timers offers a range of mobile applications based on match-making for singles. The company is based in Tokyo, Japan.
Truss
Venture Round in 2017
Truss is a Tokyo-based company that offers an online platform for comparing building materials, serving the construction industry. The platform provides comprehensive information about various building materials from multiple manufacturers, allowing users to search and compare products based on specific parameters such as performance metrics and required conditions. By consolidating building material data into a user-friendly database, Truss facilitates informed decision-making for all parties involved in construction projects, streamlining the selection and management of materials.
Smart Trade
Seed Round in 2017
Smart Trade is an information technology company that provides a web-based platform designed for investors. Its platform act as an online marketplace for investment strategy environment software. Smart Trade allows software developers to sell and upload their software online. The company was founded in 2016 and headquartered in Tokyo, Japan.
Karydo Therapeutix
Seed Round in 2016
Karydo Therapeutix, Inc. is a Tokyo-based company that specializes in developing advanced technologies for early disease detection and prevention. Utilizing its iOrgans technology platform, the company focuses on various sub-technologies, including Reverse-iOrgans, Forward-iOrgans, and Drug-iOrgans. These technologies leverage indicators to identify the earliest signs of diseases, anticipate their progression, and assess drug side effects or new applications for existing medications. By employing data science and artificial intelligence, Karydo Therapeutix visualizes the interconnectedness of organs and their functions, creating a digital twin of the body that aids in predicting future health states. Founded in 2015, the company aims to enhance the efficiency of drug development and improve health outcomes through precision research and development.
NORMEE
Venture Round in 2016
NORMEE Limited specializes in palm recognition technology that allows users to unlock their devices through unique palm patterns, including lines, ridges, veins, and capillaries. Utilizing the built-in camera of smartphones and tablets, NORMEE's system provides accurate authentication using standard visible-spectrum cameras. Founded in February 2005 and based in Tokyo, Japan, the company focuses on developing mobile biometrics technology that supports hybrid biometric authentication tailored to different operating environments. Formerly known as Universal Robot Co., Ltd., NORMEE aims to enhance security and user convenience in mobile device access.
On-Chip Biotechnologies
Venture Round in 2015
On-Chip Biotechnologies Co., Ltd. is a Tokyo-based company specializing in the development and manufacturing of advanced biosafety flow cytometers and related medical devices. Founded in 2005, the company offers innovative products such as the FISHMAN-R analyzer, which utilizes a microfluidics chip for flow cytometry. This analyzer is capable of detecting and analyzing specific bacteria and cells through the Flow-FISH method, accommodating particles ranging from 0.5μm to 20μm in size and allowing for analysis of small sample quantities. In addition to flow cytometry, On-Chip Biotechnologies produces cell sorters and droplet generators. Their cell sorting device is designed to provide damage-free and contamination-free cell separation by employing a liquid transfer system on a disposable microchannel chip, thus reducing sorter-induced cellular stress.
Gengo
Series C in 2015
Gengo’s unique platform consists of a diverse and growing community of more than 18,000 qualified translators from 114 countries working across 37 languages and 64 language pairs. The professional human translation platform represents a huge leap in quality compared to machine translation, while enjoying faster delivery times than traditional service providers. Through its web offering and open API, Gengo enables businesses of any size to quickly and easily connect with a global audience at scale. Clients and partners include JTB, TripAdvisor, BuzzFeed, Rakuten and Vestiaire Collective; a more complete list can be found at https://gengo.com/customers/ Founded in 2008, Gengo is headquartered in Tokyo, Japan with an office in Silicon Valley. To learn more about Gengo, visit www.gengo.com
Megakaryon
Series B in 2015
Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.
Cyfuse Biomedical
Venture Round in 2015
Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.
Lacras
Venture Round in 2014
Lacras Corporation, founded in 2005 and based in Tokyo, Japan, specializes in human resource management solutions. The company offers web-based HR cloud services and business process outsourcing (BPO) services that assist organizations in optimizing their HR operations. Lacras provides a comprehensive personnel database that facilitates the management of employee information, talent management functions, and the integration of data with clients' systems. This enables businesses to efficiently collect and manage personnel information, thereby streamlining their HR processes and improving overall operational effectiveness.
Jtower
Venture Round in 2014
JTOWER Inc. is a telecommunications infrastructure company based in Tokyo, Japan, specializing in infrastructure sharing services. Founded in 2012, the company focuses on the design and construction of information communication infrastructure, as well as the development of communication-related solutions. JTOWER provides a range of services that include in-building infrastructure sharing, cloud-managed Wi-Fi, outdoor tower sharing, and local 5G services, catering primarily to landlords and mobile network operators. Additionally, it offers site locator systems to facilitate the deployment of mobile infrastructure. As a subsidiary of Nippon Telegraph and Telephone Corporation, JTOWER plays a vital role in enhancing telecommunications infrastructure across Japan.
Research and Innovation
Venture Round in 2014
Research and Innovation Co., Ltd. is a market research company based in Tokyo, Japan, established in 2011. It specializes in providing marketing research, sales promotion, and information services through the Internet. The company offers a range of services, including barcode research and promotion, brand image association surveys, and investigations into consumer interests. It conducts in-store and street surveys targeting foreign tourists in Japan and serves a diverse clientele across various sectors, including food, beauty, retail, finance, and media. Additionally, Research and Innovation develops tools that analyze consumer purchasing behavior, helping businesses gain insights into promotional effectiveness and market trends, thereby facilitating revenue growth and strategic decision-making.
Looop
Seed Round in 2014
Looop Inc. is a renewable energy company based in Tokyo, Japan, established in 2011. It specializes in the construction, development, and maintenance of solar power generation systems. By managing the entire value chain, Looop aims to reduce costs and facilitate the transition to renewable energy for its customers. The company offers a range of services including the development and sales of photovoltaic power stations, construction of solar facilities, and the operation of re-energized power plants. Looop's mission is to promote sustainable living by making renewable energy accessible and hassle-free for its clients.
gumi
Series H in 2014
Gumi Inc. is a Tokyo-based entertainment company established in 2007, specializing in the development, operation, and distribution of online games for mobile devices. The company has expanded its reach beyond Japan, establishing subsidiaries across Asia, Europe, and North America. Gumi offers a variety of gaming experiences, including native applications and browser-based games, while also providing publishing services that involve localizing third-party game content for various markets. In addition to its core gaming business, Gumi is involved in emerging technologies, including virtual reality, augmented reality, and mixed reality, reflecting its commitment to innovation in the entertainment sector.
gumi
Series G in 2013
Gumi Inc. is a Tokyo-based entertainment company established in 2007, specializing in the development, operation, and distribution of online games for mobile devices. The company has expanded its reach beyond Japan, establishing subsidiaries across Asia, Europe, and North America. Gumi offers a variety of gaming experiences, including native applications and browser-based games, while also providing publishing services that involve localizing third-party game content for various markets. In addition to its core gaming business, Gumi is involved in emerging technologies, including virtual reality, augmented reality, and mixed reality, reflecting its commitment to innovation in the entertainment sector.
CMerTV Japan
Venture Round in 2013
CMer TV provides video adverts to each and every location via its own private network and enables video branding. It interacts with platforms and media in a variety of real-world contexts. They offer a platform for video advertising that works online and offline.
Octoba
Venture Round in 2012
Octoba Inc. is a Tokyo-based company founded in June 2004, specializing in the planning, development, and operation of smartphone applications. With a strong media presence since 2009, Octoba has introduced tens of thousands of applications through its platform, which includes an online review site that provides essential information for Android users. This platform facilitates the discovery and usage of various applications, enhancing the experience for users seeking mobile solutions.
gumi
Series F in 2011
Gumi Inc. is a Tokyo-based entertainment company established in 2007, specializing in the development, operation, and distribution of online games for mobile devices. The company has expanded its reach beyond Japan, establishing subsidiaries across Asia, Europe, and North America. Gumi offers a variety of gaming experiences, including native applications and browser-based games, while also providing publishing services that involve localizing third-party game content for various markets. In addition to its core gaming business, Gumi is involved in emerging technologies, including virtual reality, augmented reality, and mixed reality, reflecting its commitment to innovation in the entertainment sector.
Tella
Venture Round in 2011
Tella, Inc. is a biotechnology company based in Tokyo, Japan, focused on the research and development of regenerative and cell-based medicines, particularly dendritic cell vaccine therapy for cancer treatment. The company collaborates with medical institutions to offer operational expertise and techniques related to this therapy. Tella provides comprehensive consultation services, assisting in the establishment and maintenance of cell processing centers and management systems for cell cultivation. Additionally, it offers training for cell cultivation technicians and support for the assessment of therapies, including necessary documentation and educational resources for physicians and patients. Founded in 2004, Tella is dedicated to advancing cancer treatment through innovative immune-based therapies.
Full Speed
Post in 2010
Full Speed Inc. is a Tokyo-based company specializing in internet marketing support services in Japan. Established in 2001, it offers a comprehensive range of services including search engine optimization (SEO), listing and affiliate advertising, display advertisements, and social media advertising. The company's diverse operations are categorized into several segments: the Internet Advertising Agency focuses on listing advertising and search engine marketing solutions, while the Ad Network segment integrates various website advertising spots for effective advertisement delivery. Additionally, the Information Media segment plans and creates information sites and e-commerce platforms, and the Creative segment provides website and banner creation services. Full Speed also offers consulting in SEO and social media operations, as well as services related to advertisement effect measurement and healthcare marketing. Full Speed Inc. is a subsidiary of FreeBit Co., Ltd.
Aisei Pharmacy
Seed Round in 2010
Aisei Pharmacy engages in the retail sales of prescription drugs, proprietary drugs, and non-prescription medicines. It has a network of dispensing pharmacies with more than 350 stores nationwide and accepts prescriptions from either medical institution. It was founded in September 1984 and is located in Marunouchi Chiyoda-ku , Tokyo, Japan.
All Ads
Venture Round in 2008
All Ads is a Tokyo-based company that specializes in digital marketing services aimed at enhancing the cost-effectiveness of advertising for business professionals. By focusing on LTV marketing, All Ads combines data, technology, and consulting to optimize advertising strategies. The company provides a range of services including in-house media management, affiliate advertising consulting, operational advertising consulting, and roundtable discussions. Through its comprehensive approach, All Ads seeks to support the growth of its clients' businesses by improving their advertising performance.
Emergency Assistance Japan
Venture Round in 2007
Emergency Assistance Japan Co., Ltd., founded in 2003 and headquartered in Tokyo, offers a range of medical and lifestyle assistance services both within Japan and internationally. The company specializes in medical and security assistance programs, including support for overseas students and lifestyle services. It also provides emergency response services and assistance tailored for foreign nationals. By focusing on comprehensive risk management and coordination, Emergency Assistance Japan aims to ensure the safety and well-being of individuals while traveling or residing abroad.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.